Navigation Links
BiPar Genomic Biomarker Data Demonstrate Overexpression of PARP-1 Gene in Multiple Cancer Types
Date:10/25/2007

SAN FRANCISCO, Oct. 25 /PRNewswire/ -- BiPar Sciences, Inc., a privately held biopharmaceutical company developing novel cancer therapies, today announced molecular biomarker data demonstrating the overexpression of the PARP (poly-ADP-ribose polymerase) protein in multiple cancers, including ovarian, breast and lung tumors. The research is the first demonstration of PARP overexpression in specific types of cancer. This insight is being used to guide the clinical development of the company's pipeline of PARP inhibitor candidates.

The results were presented at the American Association for Cancer Research-National Cancer Institute-European Organization for Research and Treatment of Cancer (AACR-NCI-EORTC) International Conference on Molecular Targets and Cancer Therapeutics in San Francisco.

"These results allow us to focus our clinical development plan for BSI-201 by targeting tumors types that have the greatest probability of clinical success," said BiPar Executive Vice President Barry Sherman, M.D.

BiPar researchers used the Gene Logic Inc. BioExpress(R) System database to analyze PARP-1 gene expression in all types of primary human cancer and compared the results to normal counterpart tissue. PARP expression was above the 95 percent upper confidence limit for normal tissue in ovarian cancer, intraductal breast cancer, lung cancer and uterine cancer. In contrast, prostate tumor tissue showed minimal PARP overexpression.

BSI-201 has been tested as both monotherapy and in combination with standard therapy in Phase 1 studies in patients with solid tumors. BiPar is preparing to initiate Phase 1b and Phase 2 trials of BSI-201 in several specific tumor types guided largely by gene expression data.

About PARP

PARP-1 plays a central role in cell proliferation and in DNA repair. BiPar's novel, proprietary PARP inhibitors are a new generation of drug candidates that show promising activity and a favorable toxicity profile. Preclinica
'/>"/>

SOURCE BiPar Sciences, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Rosetta Genomics to Webcast Presentation at CE Unterberg, Towbin Emerging Growth Opportunities Conference
2. Rosetta Genomics and Weizmann Institute Scientists Identify Role of microRNA in Cancer Suppression
3. Introgen Reports Updated Phase 2 Advexin Data Correlating Improved Survival, Tumor Responses and Predictive p53 Biomarker
4. Pharmacyclics Identifies Functional Biomarkers for its Novel HDAC Inhibitor and Demonstrates Preclinical Anti-Tumor Activity with Brutons Tyrosine Kinase Inhibitors
5. Millennium Discovers Biomarkers Potentially Predictive of Response to Velcade (Bortezomib) for Injection
6. Introgen Presents ADVEXIN Biomarker Data at Major Cancer Conference
7. DNA Therapeutics Reports a Novel Mechanism of Action and a Biomarker of its Lead Molecule Dbait That Open an Innovative Pathway-Targeting in Molecular Cancer Therapy
8. Study Shows Ixabepilone Demonstrated Clear Activity in Patients with Metastatic Breast Cancer Resistant to Anthracycline, Taxane, and Capecitabine
9. The International Myeloma Foundation Says Data Reported at a Global Medical Meeting in Greece Demonstrates Improved Survival for a Wide Range of Myeloma Patients
10. Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic Control in Subjects with Type 2 Diabetes Compared to Metformin Alone
11. Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic Control in Subjects with Type 2 Diabetes Compared to Metformin Alone

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...BEDFORD, Mass., Nov. 9 H...LX ), a leading developer, manufacturer and suppli... and surgical products dedicated to serving the he...ts for the fourth quarter and fiscal year ended Se...nced the Board of Directors has promoted Robert Ca...
(Date:11/9/2009)...GLENWOOD, Ill., Nov. 9 ... in personal and environmental radiation monitorin...acquisitions in accordance with its long-term stra...e the acquisitions of Global Physics Solutions, In...Bill Saxelby, President and CEO of Landauer. "Thes...
(Date:11/9/2009)... NEW YORK, Nov. 9 /PRNewswire-Asia-FirstCall/ -...OB ), ("the Company" or "AOBO"), a pharmaceutical,...development, manufacture and,commercialization of ... ("OTC"),products, today announced that it plans t...Monday, November 16, 2009, after the market closes...
Breaking Medicine Technology:Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 2Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 3Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 4Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 5Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 7Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 8Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 9Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 10Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 11Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 12Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 13Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 14Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 15Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 16Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 17Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 18Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 19Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 20Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 21Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 22Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 23Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 24Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 25Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 26Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 27Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 28Landauer Acquires Global Physics Solutions, Inc. as Platform to Expand Into Medical Physics Services Market 2Landauer Acquires Global Physics Solutions, Inc. as Platform to Expand Into Medical Physics Services Market 3Landauer Acquires Global Physics Solutions, Inc. as Platform to Expand Into Medical Physics Services Market 4Landauer Acquires Global Physics Solutions, Inc. as Platform to Expand Into Medical Physics Services Market 5Give an Hour 28TM 29s Volunteer Mental Health Professionals Provide Nearly 241 7 Million in Services to Iraq and Afghanistan Veterans Families and 56394 1Give an Hour 28TM 29s Volunteer Mental Health Professionals Provide Nearly 241 7 Million in Services to Iraq and Afghanistan Veterans Families and 56394 2Reportlinker Adds Small Molecule Kinase Inhibitors Report 13902 1Reportlinker Adds Small Molecule Kinase Inhibitors Report 13902 2Reportlinker Adds Small Molecule Kinase Inhibitors Report 13902 3Reportlinker Adds Small Molecule Kinase Inhibitors Report 13902 4Reportlinker Adds Small Molecule Kinase Inhibitors Report 13902 5Reportlinker Adds Small Molecule Kinase Inhibitors Report 13902 6Reportlinker Adds Small Molecule Kinase Inhibitors Report 13902 7Reportlinker Adds Small Molecule Kinase Inhibitors Report 13902 8Reportlinker Adds Small Molecule Kinase Inhibitors Report 13902 9Reportlinker Adds Small Molecule Kinase Inhibitors Report 13902 10Environmentally green beer 3A Munich brewing engineers research energy savings 9825 1Environmentally green beer 3A Munich brewing engineers research energy savings 9825 2Environmentally green beer 3A Munich brewing engineers research energy savings 9825 3
...001, an Intravenous Recombinant Factor IX (rFIX) P...NA NIGUEL, Calif., Feb. 12 Inspiration Biopharmac...a Phase 1 clinical trial of IB1001, an intravenous...trol and prevention of hemorrhagic episodes in pat... market for therapies to treat this disorder is in...
...HESTER, Minn., Feb. 11 In a study published in T...archers led by Mayo Clinic psychiatrist Mark Frye,...e people with bipolar depression more likely to ex...lar disorder, also known as manic-depressive illne...od instability that can be serious and disabling. ...
Other Medicine Technology:Inspiration Biopharmaceuticals, Inc. Initiates Phase 1 Clinical Trial of IB1001 for the Treatment of Hemophilia B 2Study Suggests New Treatment Approach May be Needed for Management of Depression in Some People With Bipolar Disorder 2Study Suggests New Treatment Approach May be Needed for Management of Depression in Some People With Bipolar Disorder 3
(Date:11/9/2009)... Campaign Backed by USDA Secretary Vilsack, Govern...BOSTON, Nov. 9 In a gro...James P. McGovern (D-Worcester) called for all of ...lping hungry patients in their care. ,, "With ..." said McGovern at today,s press conference at UMa...
(Date:11/9/2009)... Lung Cancer Awareness Month Highlighted During Br...wswire/ -- Lung Cancer Alliance (LCA) announced th...Closing Bell for the New York Stock Exchange(TM) (...: http://www.newscom.com/cgi-bin/prnh/20081016/L...urvivor and LCA-NY advocate, Richard Heimler will ...
(Date:11/9/2009)...RIVERWOODS, Ill., Nov. 9 The House...ealth Care for America Act , which passed by a vot...tes several significant changes to the tax code an...ely to appear in any Senate version, requiring ext...H has issued a Special Tax Briefing on the tax...
(Date:11/9/2009)... SBA Provision, Antitrust Language, Federal Trade ...ate ,, WASHINGTON, Nov. 9 /PRNewswire-USNewswi...Health Care for America Act (H.R. 3962) allowing i... health insurance exchanges is positive, but other...rding to the National Association of Professional ...
(Date:11/9/2009)... House action backs President Obama,s promise to n...e example ,, Bishops still concerned for poor...Newswire/ -- Cardinal Francis George of Chicago, p...ic Bishops, lauded the November 7 decision of the ...lth care reform money from paying for elective abo...
Breaking Medicine News(10 mins):Health News:McGovern and Project Bread Launch Hospital Hunger Initiative 2Health News:McGovern and Project Bread Launch Hospital Hunger Initiative 3Health News:Lung Cancer Alliance Staff and Advocates to Ring Closing Bell of New York Stock Exchange(TM) 2Health News:CCH Briefing Details Tax Provisions of House Health Care Bill 2Health News:PIA Says Inclusion of Agents in House Healthcare Bill is Positive, But Concerns Remain 2Health News:PIA Says Inclusion of Agents in House Healthcare Bill is Positive, But Concerns Remain 3Health News:Cardinal George Lauds House Action to Ban Federal Funds for Abortion; Promises Vigilance as Senate Pursues Health Care Reform, Wary About Affect on Poor, Elderly 2Health News:Cardinal George Lauds House Action to Ban Federal Funds for Abortion; Promises Vigilance as Senate Pursues Health Care Reform, Wary About Affect on Poor, Elderly 3
...30% Increase in Physician and Nurse Training Neede...il on Physician and,Nurse Supply, an independent g... of Pennsylvania, has called on the White House to...one,expanded, unless we educate more nurses and ph...
...SCHAUMBURG, Ill., March 26 For decades, the Ameri...to practice proper sun,protection to prevent skin ...spite any claims to the contrary., "While the hea...st C. William Hanke, MD, FAAD, president of the Am...
..., This release is available in Spanish . , Ig... Department of Microbiology and Parasitology of th...ct for the detection and characterization of the B...der the brand name Bruce-ladder, and was developed...
...ST. JOSEPH, Mich., March 26 GeneGo, Inc., the lea...y the release of MetaMiner,Cystic Fibrosis, a firs...ned to help advance drug discovery for cystic fibr...methods for integrating and analyzing cystic fibro...
...BLOOMFIELD HILLS, Mich., March 26 The next phase ... industry will be lead by,CJPS Enterprises, LLC (...s was,assigned by the Michigan Economic Developmen...reated through the $2,billion 21st Century Jobs Fu...
...Three in Five Caregivers Say Their Children Help C...lzheimer,s Disease, NEW YORK, March 26 Results f...rica (AFA) ICAN: Investigating Caregivers,Attitude...21 who also care for an aging parent, other relati...
Other Medicine News:Health News:Council Calls on White House to Convene Conference on Physician and Nurse Supply 2Health News:American Academy of Dermatology Issues Statement Urging the Public to be Sun Smart(SM) 2Health News:A product for the detection and characterization of brucellosis launched at University of Navarra 2Health News:GeneGo Rolls out MetaMiner Cystic Fibrosis - the First Disease-Specific Software Platform to Advance Drug Discovery 2Health News:GeneGo Rolls out MetaMiner Cystic Fibrosis - the First Disease-Specific Software Platform to Advance Drug Discovery 3Health News:CJPS Enterprises to Expand Efforts of 21st Century Jobs Fund Life Sciences Pipeline 2Health News:New Alzheimer's Disease Survey Reveals Children of Sandwich Caregivers Assist With Loved Ones' Care 2Health News:New Alzheimer's Disease Survey Reveals Children of Sandwich Caregivers Assist With Loved Ones' Care 3Health News:New Alzheimer's Disease Survey Reveals Children of Sandwich Caregivers Assist With Loved Ones' Care 4Health News:New Alzheimer's Disease Survey Reveals Children of Sandwich Caregivers Assist With Loved Ones' Care 5
...retinal surgery. ,By using Perfluoron, a liquid ...can greatly expand your surgical capabilities. Per...complicated by proliferative vitreoretinopathy, gi...be >99.9 percent pure, Perfluoron is the purest pe...
Epocrates Rx
...Pipette is a synonym for pipetting accuracy, a smo...ior operating comfort. Its single, multifunctional...d blow-out as well as eject the tip. Product featu...accuracy and precision. Ejection sleeve can be rem...
STELLARA™
Medicine Products: